| Product Code: ETC5821305 | Publication Date: Nov 2023 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
In 2024, Ireland continued to rely heavily on biologics imports from top countries including the USA, UK, Germany, Metropolitan France, and Serbia, indicating a concentrated market. Despite a concerning negative CAGR of -4.18% from 2020 to 2024, the growth rate in 2024 saw a steep decline of -30.16%. This suggests a challenging landscape for biologics imports in Ireland, highlighting the need for strategic interventions and market diversification to stimulate growth and reduce dependency on a few key exporting nations.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Biologics Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Biologics Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Biologics Market - Industry Life Cycle |
3.4 Ireland Biologics Market - Porter's Five Forces |
3.5 Ireland Biologics Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.6 Ireland Biologics Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Ireland Biologics Market Revenues & Volume Share, By Disease? Category, 2021 & 2031F |
3.8 Ireland Biologics Market Revenues & Volume Share, By Biologics Manufacturing, 2021 & 2031F |
4 Ireland Biologics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for biologics in the treatment of chronic diseases |
4.2.2 Growing investments in research and development of biologics |
4.2.3 Favorable government regulations supporting the biologics market growth |
4.3 Market Restraints |
4.3.1 High costs associated with the development and manufacturing of biologics |
4.3.2 Stringent regulatory requirements for approval of biologics products |
5 Ireland Biologics Market Trends |
6 Ireland Biologics Market Segmentations |
6.1 Ireland Biologics Market, By Source |
6.1.1 Overview and Analysis |
6.1.2 Ireland Biologics Market Revenues & Volume, By Microbial, 2021-2031F |
6.1.3 Ireland Biologics Market Revenues & Volume, By Mammalian, 2021-2031F |
6.1.4 Ireland Biologics Market Revenues & Volume, By Others, 2021-2031F |
6.2 Ireland Biologics Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Biologics Market Revenues & Volume, By Monoclonal Antibodies, 2021-2031F |
6.2.3 Ireland Biologics Market Revenues & Volume, By Vaccines, 2021-2031F |
6.2.4 Ireland Biologics Market Revenues & Volume, By Recombinant Proteins, 2021-2031F |
6.2.5 Ireland Biologics Market Revenues & Volume, By Antisense, RNAi, & Molecular Therapy, 2021-2031F |
6.2.6 Ireland Biologics Market Revenues & Volume, By Others, 2021-2031F |
6.3 Ireland Biologics Market, By Disease? Category |
6.3.1 Overview and Analysis |
6.3.2 Ireland Biologics Market Revenues & Volume, By Oncology, 2021-2031F |
6.3.3 Ireland Biologics Market Revenues & Volume, By Infectious Diseases, 2021-2031F |
6.3.4 Ireland Biologics Market Revenues & Volume, By Immunological Disorders, 2021-2031F |
6.3.5 Ireland Biologics Market Revenues & Volume, By Cardiovascular Disorders, 2021-2031F |
6.3.6 Ireland Biologics Market Revenues & Volume, By Hematological Disorders, 2021-2031F |
6.3.7 Ireland Biologics Market Revenues & Volume, By Others, 2021-2031F |
6.4 Ireland Biologics Market, By Biologics Manufacturing |
6.4.1 Overview and Analysis |
6.4.2 Ireland Biologics Market Revenues & Volume, By Outsourced, 2021-2031F |
6.4.3 Ireland Biologics Market Revenues & Volume, By In-house, 2021-2031F |
7 Ireland Biologics Market Import-Export Trade Statistics |
7.1 Ireland Biologics Market Export to Major Countries |
7.2 Ireland Biologics Market Imports from Major Countries |
8 Ireland Biologics Market Key Performance Indicators |
8.1 Number of clinical trials for biologics in Ireland |
8.2 Percentage of healthcare professionals trained in prescribing and administering biologics |
8.3 Investment in biologics research and development in Ireland |
8.4 Number of partnerships and collaborations between biopharmaceutical companies in Ireland |
8.5 Patient access and adoption rates of biologics in the Irish healthcare system |
9 Ireland Biologics Market - Opportunity Assessment |
9.1 Ireland Biologics Market Opportunity Assessment, By Source, 2021 & 2031F |
9.2 Ireland Biologics Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Ireland Biologics Market Opportunity Assessment, By Disease? Category, 2021 & 2031F |
9.4 Ireland Biologics Market Opportunity Assessment, By Biologics Manufacturing, 2021 & 2031F |
10 Ireland Biologics Market - Competitive Landscape |
10.1 Ireland Biologics Market Revenue Share, By Companies, 2024 |
10.2 Ireland Biologics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here